Cargando…

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Detalles Bibliográficos
Autores principales: Chen, Shiqi, Huang, Zehong, Guo, Yue, Guo, Huilin, Jian, Lijuan, Xiao, Jin, Yao, Xiangyang, Yu, Hai, Cheng, Tong, Zhang, Yali, Guan, Ming, Mao, Richeng, Zhang, Jiming, Xia, Ningshao, Yuan, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439137/
https://www.ncbi.nlm.nih.gov/pubmed/37596249
http://dx.doi.org/10.1038/s41421-023-00584-6
_version_ 1785092877026590720
author Chen, Shiqi
Huang, Zehong
Guo, Yue
Guo, Huilin
Jian, Lijuan
Xiao, Jin
Yao, Xiangyang
Yu, Hai
Cheng, Tong
Zhang, Yali
Guan, Ming
Mao, Richeng
Zhang, Jiming
Xia, Ningshao
Yuan, Quan
author_facet Chen, Shiqi
Huang, Zehong
Guo, Yue
Guo, Huilin
Jian, Lijuan
Xiao, Jin
Yao, Xiangyang
Yu, Hai
Cheng, Tong
Zhang, Yali
Guan, Ming
Mao, Richeng
Zhang, Jiming
Xia, Ningshao
Yuan, Quan
author_sort Chen, Shiqi
collection PubMed
description
format Online
Article
Text
id pubmed-10439137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-104391372023-08-20 Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies Chen, Shiqi Huang, Zehong Guo, Yue Guo, Huilin Jian, Lijuan Xiao, Jin Yao, Xiangyang Yu, Hai Cheng, Tong Zhang, Yali Guan, Ming Mao, Richeng Zhang, Jiming Xia, Ningshao Yuan, Quan Cell Discov Correspondence Springer Nature Singapore 2023-08-18 /pmc/articles/PMC10439137/ /pubmed/37596249 http://dx.doi.org/10.1038/s41421-023-00584-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Chen, Shiqi
Huang, Zehong
Guo, Yue
Guo, Huilin
Jian, Lijuan
Xiao, Jin
Yao, Xiangyang
Yu, Hai
Cheng, Tong
Zhang, Yali
Guan, Ming
Mao, Richeng
Zhang, Jiming
Xia, Ningshao
Yuan, Quan
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title_full Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title_fullStr Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title_full_unstemmed Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title_short Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
title_sort evolving spike mutations in sars-cov-2 omicron variants facilitate evasion from breakthrough infection-acquired antibodies
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439137/
https://www.ncbi.nlm.nih.gov/pubmed/37596249
http://dx.doi.org/10.1038/s41421-023-00584-6
work_keys_str_mv AT chenshiqi evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT huangzehong evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT guoyue evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT guohuilin evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT jianlijuan evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT xiaojin evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT yaoxiangyang evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT yuhai evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT chengtong evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT zhangyali evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT guanming evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT maoricheng evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT zhangjiming evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT xianingshao evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies
AT yuanquan evolvingspikemutationsinsarscov2omicronvariantsfacilitateevasionfrombreakthroughinfectionacquiredantibodies